Apremilast in scalp psoriasis

Apremilast is a new oral treatment of psoriasis. In this trial, we are looking for the efficacy of apremilast on quality of life in scalp psoriasis.

Team

Alexander Navarini, Prof. Dr. med. Dr. sc.nat.
M. Drach, MD univ.
T. Meyer, Leitung Studienkoordination
J. Püschel, Studienkoordination

Running since

Planning stage

We Value Your Privacy!

We and our partners are using technologies like cookies and process personal data like the IP-address or browser information in order to analyze the website data. This helps us to improves your internet experience. We also use it in order to measure results or align our website content. Because we value your privacy, we are herewith asking for your permission to use these technologies. You can always change/withdraw your consent later.

Necessary Cookies

Analytics